731 related articles for article (PubMed ID: 18716620)
1. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
Morotti A; Panuzzo C; Crivellaro S; Pergolizzi B; Familiari U; Berger AH; Saglio G; Pandolfi PP
Leukemia; 2014 Jun; 28(6):1326-33. PubMed ID: 24317448
[TBL] [Abstract][Full Text] [Related]
3. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; García F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
[TBL] [Abstract][Full Text] [Related]
5. The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.
Song MS; Song SJ; Kim SY; Oh HJ; Lim DS
EMBO J; 2008 Jul; 27(13):1863-74. PubMed ID: 18566590
[TBL] [Abstract][Full Text] [Related]
6. Identification of a tumour suppressor network opposing nuclear Akt function.
Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
[TBL] [Abstract][Full Text] [Related]
7. Daxx is reciprocally regulated by Mdm2 and Hausp.
Tang J; Qu L; Pang M; Yang X
Biochem Biophys Res Commun; 2010 Mar; 393(3):542-5. PubMed ID: 20153724
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
9. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
[TBL] [Abstract][Full Text] [Related]
10. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
Sarkari F; Wang X; Nguyen T; Frappier L
PLoS One; 2011 Jan; 6(1):e16598. PubMed ID: 21305000
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
Zhang XW; Yan XJ; Zhou ZR; Yang FF; Wu ZY; Sun HB; Liang WX; Song AX; Lallemand-Breitenbach V; Jeanne M; Zhang QY; Yang HY; Huang QH; Zhou GB; Tong JH; Zhang Y; Wu JH; Hu HY; de Thé H; Chen SJ; Chen Z
Science; 2010 Apr; 328(5975):240-3. PubMed ID: 20378816
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination.
Yeung PL; Denissova NG; Nasello C; Hakhverdyan Z; Chen JD; Brenneman MA
J Cell Biochem; 2012 May; 113(5):1787-99. PubMed ID: 22213200
[TBL] [Abstract][Full Text] [Related]
13. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
14. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.
Isakson P; Bjørås M; Bøe SO; Simonsen A
Blood; 2010 Sep; 116(13):2324-31. PubMed ID: 20574048
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
16. New insights into the cytoplasmic function of PML.
Salomoni P; Bellodi C
Histol Histopathol; 2007 Aug; 22(8):937-46. PubMed ID: 17503350
[TBL] [Abstract][Full Text] [Related]
17. HAUSP compartmentalization in chronic myeloid leukemia.
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G
Eur J Haematol; 2015 Apr; 94(4):318-21. PubMed ID: 25082234
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
19. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
Zhu G
Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
[TBL] [Abstract][Full Text] [Related]
20. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H
J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]